Evolent Health Explores Sale Amid Interest from Private Equity Giants

Evolent Health is considering a potential sale as it receives interest from private equity firms such as TPG, CD&R, and KKR, as well as health insurer Elevance Health. The company, valued at $3.3 billion, is working with a financial adviser and initial bids have been received. A deal could be finalized in the coming weeks.

Evolent Health, a prominent healthcare services provider, is exploring a potential sale following inbound interest, sources revealed on Thursday.

Private equity firms including TPG, CD&R, and KKR have shown interest, alongside health insurer Elevance Health, which may partner with a private equity firm to acquire Evolent. Currently valued at $3.3 billion, Evolent is working with a financial adviser and initial bids have been submitted, sources stated.

While discussions are confidential and a final deal is not guaranteed, a resolution could be expected in the next few weeks. Evolent and the interested parties declined to comment on the developments.

(With inputs from agencies.)